KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Biolife Solutions (BLFS) over the last 10 years, with Q3 2025 value amounting to $1.4 million.

  • Biolife Solutions' Treasury Shares fell 3095.08% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year decrease of 3095.08%. This contributed to the annual value of $1.3 million for FY2024, which is 4398.2% down from last year.
  • According to the latest figures from Q3 2025, Biolife Solutions' Treasury Shares is $1.4 million, which was down 3095.08% from $1.5 million recorded in Q2 2025.
  • Biolife Solutions' Treasury Shares' 5-year high stood at $2.3 million during Q4 2023, with a 5-year trough of $888294.0 in Q2 2021.
  • Its 5-year average for Treasury Shares is $1.6 million, with a median of $1.4 million in 2023.
  • Per our database at Business Quant, Biolife Solutions' Treasury Shares skyrocketed by 8761.96% in 2021 and then plummeted by 4398.2% in 2024.
  • Quarter analysis of 5 years shows Biolife Solutions' Treasury Shares stood at $1.2 million in 2021, then surged by 54.95% to $1.9 million in 2022, then rose by 23.08% to $2.3 million in 2023, then tumbled by 43.98% to $1.3 million in 2024, then grew by 5.52% to $1.4 million in 2025.
  • Its last three reported values are $1.4 million in Q3 2025, $1.5 million for Q2 2025, and $1.4 million during Q1 2025.